As of 2025-07-07, the Relative Valuation of Protalix Biotherapeutics Inc (PLX) is 1.54 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of Protalix Biotherapeutics Inc based on Relative Valuation is 0.1%.
The range of the Relative Valuation is 1.54 - 1.54 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 31.4x | 31.4x |
| Forward P/E multiples | 14.7x - 14.7x | 14.7x |
| Fair Price | 1.54 - 1.54 | 1.54 |
| Upside | 0.0% - 0.1% | 0.1% |
| Date | P/E |
| 2025-07-03 | 31.37 |
| 2025-07-02 | 30.56 |
| 2025-07-01 | 30.15 |
| 2025-06-30 | 30.15 |
| 2025-06-27 | 31.37 |
| 2025-06-26 | 29.54 |
| 2025-06-25 | 28.72 |
| 2025-06-24 | 31.17 |
| 2025-06-23 | 27.50 |
| 2025-06-20 | 28.52 |
| 2025-06-18 | 28.52 |
| 2025-06-17 | 27.91 |
| 2025-06-16 | 29.13 |
| 2025-06-13 | 30.35 |
| 2025-06-12 | 31.37 |
| 2025-06-11 | 31.98 |
| 2025-06-10 | 32.19 |
| 2025-06-09 | 31.37 |
| 2025-06-06 | 32.19 |
| 2025-06-05 | 30.96 |
| 2025-06-04 | 32.59 |
| 2025-06-03 | 32.59 |
| 2025-06-02 | 32.19 |
| 2025-05-30 | 31.58 |
| 2025-05-29 | 32.39 |
| 2025-05-28 | 32.39 |
| 2025-05-27 | 31.78 |
| 2025-05-23 | 33.00 |
| 2025-05-22 | 33.61 |
| 2025-05-21 | 34.83 |
| 2025-05-20 | 35.04 |
| 2025-05-19 | 34.22 |
| 2025-05-16 | 34.02 |
| 2025-05-15 | 34.02 |
| 2025-05-14 | 34.02 |
| 2025-05-13 | 33.82 |
| 2025-05-12 | 29.74 |
| 2025-05-09 | 35.04 |
| 2025-05-08 | 58.87 |
| 2025-05-07 | 57.85 |
| 2025-05-06 | 55.61 |
| 2025-05-05 | 57.85 |
| 2025-05-02 | 61.11 |
| 2025-05-01 | 61.11 |
| 2025-04-30 | 62.54 |
| 2025-04-29 | 60.30 |
| 2025-04-28 | 58.06 |
| 2025-04-25 | 58.06 |
| 2025-04-24 | 59.89 |
| 2025-04-23 | 60.30 |